We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Once-a-Week Asthma Drug Shows Promise

By HospiMedica staff writers
Posted on 31 Jan 2002
A new asthma drug that may need be taken only once a week is one of a new class of drugs that shows promise for treating respiratory disorders.

A clinical trial has shown that a single dose of the new drug, EPI-2010, substantially reduced the need of the 14 asthma patients in the study to use their bronchodilator medicine to control asthma symptoms, an effect that lasted for an entire week. More...
The drug is the first of a new class of drugs called respirable antisense oligonucleotides (RASONS). RASONS offer the potential for a series of important medicines, says the developer, EpiGenesis Pharmaceuticals, Inc. (Cranbury, NJ, USA). The company, the first to test RASONS in clinical trials, plans to sublicense EPI-2010 to a multinational pharmaceutical company for sales and distribution.

"An effective, once-per-week asthma drug would be a medical breakthrough,” said Prof. Peter Barnes, head of thoracic medicine at the National Heart & Lung Institute (London, UK). "We await completion of EPI-2010's remaining clinical trial with great anticipation.”




Related Links:
EpiGenesis

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Syringe Pump
SP50 Series
New
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.